We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Hematology

Image: Blood test could shorten hospital stays for children with cancer (Photo courtesy of University of York)

Novel Blood Test Could Cut Hospital Stays for Children with Cancer

A study, by researchers from the University of York (York, UK) and Hull York Medical School (York, UK) reveals that a blood test can help doctors to distinguish between children whose fever is a sign of serious illness and those who are safe to go home. The results of the study show that using the blood test in combination with a new protocol to identify children that are safe to go home, cuts their average stay in hospital down to two days, with some able to leave in as little as eight hours. More...
21 Mar 2022
Image: Personalized blood test for cancer patients (Photo courtesy of University of Cambridge)

Personalized Blood Test Can Detect Persistent Lung Cancer

By finding signs that lung cancer cells might still be present and active after treatment, using methods such a liquid biopsy, doctors might be able make better choices about treating patients, aiming to improve the chances of survival for patients who are at higher risk while reducing side effects for patients who are at a lower risk group, according to results from a new study. More...
21 Mar 2022
Image: New method identifies thousands of DNA mutations accurately (Photo courtesy of Broad Institute)

New Technique Improves Detection of Cancer DNA in Blood

Researchers have now developed a new method to identify thousands of DNA mutations accurately and efficiently in a patient's blood sample with minimal sequencing. The approach, called MAESTRO, developed by a team of researchers at Broad Institute (Cambridge, MA, USA), could one day enable the detection of residual cancer in patients who have undergone treatment, alerting doctors to disease recurrence earlier and more cheaply than current techniques allow. More...
21 Mar 2022
Image: The ACL-TOP 750 LAS coagulation analyzer (Photo courtesy of Werfen)

Capillary and Venous Blood Sampling Compared for Coagulation Assays

Capillary blood samples are generally assumed as unsuitable for coagulation testing since it is recognized that contamination with tissue factor and dilution with tissue fluid affects the coagulation assay. However, limited data is available about coagulations assays in which capillary blood sampling is compared to the standard venous blood withdrawal method. The aim of this study was to perform a method comparison between capillary and venous blood sampling for routine coagulation assays. More...
17 Mar 2022
Image: BC-700 Series Integrated CBC and ESR Hematology Analyzer (Photo courtesy of Mindray)

Mindray Launches BC-700 Series Integrated CBC and ESR Hematology Analyzer for Small-to-Mid Sized Labs

A first all-in-one hematology solution that combines 5-part differential with ESR analysis yields both CBC and ESR results with just one test in merely 1.5 minutes, significantly improving workflow and testing efficiency while benefiting patients with quicker blood test reports. More...
17 Mar 2022
Image: The cobas t 711 coagulation analyzer (Photo courtesy of Roche Diagnostics)

New One-Stage Factor VIII Assay Evaluated

We conducted a multicenter evaluation of a new one-stage factor VIII (FVIII) assay (Roche Diagnostics), intended for the quantitative assessment of FVIII activity. We evaluated the analytical performance of the FVIII assay on the cobas t 711 analyzer. More...
17 Mar 2022
Image: New assay enables simultaneous determination of total Aβ40 and Aβ42 levels (Photo courtesy of Araclon Biotech)

Unique Diagnostic Test Based on Mass Spectrometry Technique Accurately Identifies Early-Stage Alzheimer's Disease

Cerebral amyloid load is one of the first signs of early-onset Alzheimer's Disease (AD) in individuals with subjective memory complaints (SMCs) and has potential for use as a biomarker to indicate how the condition evolves. A new assay based on mass spectrometry has shown to be capable of quantifying amyloid-beta 40 and 42 proteins – both associated with the risk of having AD – in plasma samples. More...
16 Mar 2022
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV


The Hematology channel at LabMedica covers the all aspect of plasma, coagulation, transfusion medicine, and blood banking, as well as related lab tools and techniques.
Copyright © 2000-2024 Globetech Media. All rights reserved.